Priority Date: 21.05.12 (US 201261649847P)

LEDGF PEPTIDES AND FORMULATIONS THEREOF FOR TREATMENT OF DEGENERATIVE DISORDERS

  • Application ID: EP13794410
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorneys

no operation time available
3 offices
active in Legal Services
operating since 1887
1447.57
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading
operating since 1887
1447.57
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading
Employment test 11 - 50 employees
Company dna zbm patents sl
operating since 2003
Headquarter in Barcelona and 3 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC combination A61, C07, and C12. ZBM Patents Zea, Barlocci & Markvardsen SL and Rouse IP Limited are specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 120 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.05.2012 - Priority Date (US 201261649847P)
  • 28.11.2013 - Publication A1 (WO2013177198)
  • 01.04.2015 - Publication A1 (EP2852399)

IPC Classification